ArticleJournal of cancer research and clinical oncology2025

A novel strategy for sorafenib-resistant hepatocellular carcinoma: autotaxin Inhibition by PF-8380.

Bong Jun Kwak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.